Study on bioequivalence exemption for levofloxacin tablets post-excipient modification*

WANG Wen-li, ZHANG Xiao-yan, WANG Xiao-jing, YU Li-ju, ZHANG Xiao-ming, SUN Ying

Chinese Journal of Pharmaceutical Analysis ›› 2024, Vol. 44 ›› Issue (7) : 1212-1221.

PDF(4861 KB)
PDF(4861 KB)
Chinese Journal of Pharmaceutical Analysis ›› 2024, Vol. 44 ›› Issue (7) : 1212-1221. DOI: 10.16155/j.0254-1793.2024-0089
Safety Monitoring

Study on bioequivalence exemption for levofloxacin tablets post-excipient modification*

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 44(7): 1212-1221 https://doi.org/10.16155/j.0254-1793.2024-0089

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(4861 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Journal of Pharmaceutical Analysis, All Rights Reserved.
E-mail：ywfx@nifdc.org.cn
Powered by Beijing Magtech Co. Ltd.

/

〈 〉